Tramadol Hydrochloride Tablet, Extended Release
Product Images NDC 70518-0886

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 70518-0886). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7848ebcb 7a13 48a8 Bbeb 7481d040c068 01

Chemical structure of the active ingredient Tramadol Hydrochloride, showing molecular bonds and functional groups as part of the drug's molecular formula representation.*

FDA Label Image

7848ebcb 7a13 48a8 Bbeb 7481d040c068 02

A line graph comparing tramadol concentration (ng/mL) over 24 hours for two formulations: Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily (black circles) and Tramadol Hydrochloride Tablets 50 mg every 6 hours (white circles). The graph shows concentration changes on the y-axis and time in hours on the x-axis.*

FDA Label Image

7848ebcb 7a13 48a8 Bbeb 7481d040c068 03

A graph comparing M1 metabolite concentration (ng/mL) over 24 hours for Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily versus Tramadol Hydrochloride Tablets 50 mg every 6 hours. The x-axis represents time in hours, and the y-axis shows M1 concentration. Data points are shown for both dosage forms, illustrating their concentration-time profiles.*

FDA Label Image

7848ebcb 7a13 48a8 Bbeb 7481d040c068 04

A line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 023 WOMAC Pain Responder Analysis' showing the percent of patients achieving various levels of pain response improvement from baseline. The graph compares response rates for Tramadol Hydrochloride Extended-Release Tablets at 100 mg, 200 mg, 300 mg, 400 mg, and Placebo across response thresholds from 0% to 100% improvement. Each dosage is represented by a distinct line pattern and marker type.*

FDA Label Image

7848ebcb 7a13 48a8 Bbeb 7481d040c068 05

A line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 015 Arthritis Pain Intensity VAS Responder Analysis Patients Achieving Various Levels of Response Threshold.' It depicts the percent of patients achieving response on the vertical axis versus response threshold (percent improvement from baseline) on the horizontal axis. Two lines compare Tramadol Hydrochloride Extended-Release Tablets and placebo, showing a higher percentage of patients achieving response with the medication across various thresholds.*

FDA Label Image

Tramadol HCl 200mg 70518 0886 00

Label for TRAMADOL HYDROCHLORIDE extended-release 200 mg tablets, oral use, with a quantity of 30 tablets. The label shows the drug as schedule C-IV, intended for prescription use only, and includes the NDC number 70518-0886-00. It also mentions repackaging by RemedyRepack Inc. and manufacturing by Lupin Pharma.*

FDA Label Image

Tramadol HCl 200mg 70518 0886 01

Label for TRAMADOL HYDROCHLORIDE extended-release 200 mg oral tablets by RemedyRepack Inc. The label shows 30 tablets, designated as Schedule C-IV. It includes the NDC 70518-0886-01, manufacturer Lupin Pharma Baltimore MD, storage instructions, and directions to see package insert.*

FDA Label Image

Tramadol HCl 200mg 70518 0886 02

Label for TRAMADOL HYDROCHLORIDE extended-release 200 mg tablets, quantity 90, classified as C-IV. The label shows the product as oral extended-release tablets with a highlighted strength of 200 mg. It includes the NDC number 70518-0886-02 and states repackaging by RemedyRepack Inc. Manufacturer Lupin Pharma is listed with address Baltimore, MD. Warning to keep medication out of reach of children and directions to see package insert are present.*

FDA Label Image

Tramadol HCl 200mg 70518 0886 03

Label for TRAMADOL HYDROCHLORIDE 200 mg extended-release oral tablets, packaged in a quantity of 60. The label indicates the product is a Schedule IV controlled substance and repackaged by RemedyRepack Inc. Information includes NDC number 70518-0886-03, source manufacturer Lupin Pharma in Baltimore, MD, and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.